These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2698951)

  • 1. Changes in peripheral venous distensibility and blood pressure modifications in borderline hypertension: evidence against a primary role for the renin-angiotensin-aldosterone system.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    J Hypertens Suppl; 1989 Dec; 7(6):S80-1. PubMed ID: 2698951
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of pharmacological modulation of the renin-angiotensin-aldosterone system on salt sensitivity in patients with borderline hypertension.
    Borghi C; Boschi S; Costa FV; Bacchelli S; Degli Esposti D; Piccoli M; Ambrosioni E
    J Hypertens Suppl; 1993 Dec; 11(5):S248-9. PubMed ID: 8158368
    [No Abstract]   [Full Text] [Related]  

  • 3. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
    Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
    J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial natriuretic factor response to acute volume expansion in borderline hypertension. Role of ACE-inhibition and changes in peripheral venous tone.
    Borghi C; Boschi S; Costa FV; Ambrosioni E
    Clin Exp Hypertens; 1993 Mar; 15(2):339-54. PubMed ID: 8467321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake.
    Gudmundsson O; Andersson OK; Aurell M; Wikstrand JM; Berglund GL
    J Hypertens; 1984 Jun; 2(3):291-6. PubMed ID: 6397530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
    Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
    Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nitrendipine on blood pressure, renin-angiotensin system, and kidney function in essential hypertension.
    Glorioso N; Manunta P; Troffa C; Pazzola A; Soro A; Pala F; Melis MG; Madeddu P; Tonolo G
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S142-5. PubMed ID: 2468859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PG synthesis by indomethacin does not influence the exercise induced stimulation of renin-angiotensin-aldosterone system in hypertensives treated with captopril.
    Novo S; Adamo L; Nardi E; Licata G; Strano A
    Prog Clin Biol Res; 1987; 242():387-92. PubMed ID: 3313416
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute hemodynamic effects of drugs acting on the renin-angiotensin system in acute heart failure.
    Nekooeian AA; Ogilvie RI; Zborowska-Sluis D
    Can J Cardiol; 1995 Jan; 11(1):59-64. PubMed ID: 7850666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of captopril on renin-aldosterone system in essential hypertension].
    Yu ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):84-5. PubMed ID: 3058446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the indicators of the renin-angiotensin-aldosterone system, kallikrein-kinin system and arterial blood pressure in elderly patients with essential hypertension treated with captopril].
    Khartrodt V; Brozovskiĭ KKh; Beuer E; Gurke R; Faulhaber H
    Kardiologiia; 1988 Dec; 28(12):54-6. PubMed ID: 3072445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurohumoral mechanisms regulating renal blood circulation in patients with hypertension undergoing captopril block of angiotensin-converting enzyme].
    Almazov VA; Ametov AS; Shliakhto EV; Dolgova IB; Pushkarev AA
    Ter Arkh; 1989; 61(8):13-5. PubMed ID: 2573961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
    Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
    Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of water immersion and captopril on secretion of atrial natriuretic peptide and the activity of the renin-angiotensin system in essential hypertension].
    Wiecek A; Kokot F; Drobisz M; Grzeszczak W
    Kardiol Pol; 1991; 34(4):231-9. PubMed ID: 1833578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.